HomeMarketsDiscoverWatchlistPortfoliosScreener
Sign Up or Login
  • France

French Pharma Stock News

ENXTPA:IPN
ENXTPA:IPNPharmaceuticals

Are Investors Undervaluing Ipsen S.A. (EPA:IPN) By 31%?

September 28, 2023
Key Insights The projected fair value for Ipsen is €178 based on 2 Stage Free Cash Flow to Equity Current share price...
ENXTPA:EAPI
ENXTPA:EAPIPharmaceuticals

Euroapi S.A.'s (EPA:EAPI) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

September 27, 2023
Euroapi's (EPA:EAPI) stock is up by a considerable 16% over the past three months. We wonder if and what role the...
ENXTPA:VIRP
ENXTPA:VIRPPharmaceuticals

Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?

September 26, 2023
Key Insights Virbac's estimated fair value is €411 based on 2 Stage Free Cash Flow to Equity Current share price of...
ENXTPA:VETO
ENXTPA:VETOPharmaceuticals

Is Vetoquinol SA (EPA:VETO) Trading At A 45% Discount?

September 12, 2023
Key Insights Using the 2 Stage Free Cash Flow to Equity, Vetoquinol fair value estimate is €148 Vetoquinol's €81.10...
ENXTPA:IPN
ENXTPA:IPNPharmaceuticals

These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well

September 07, 2023
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
ENXTPA:VIRP
ENXTPA:VIRPPharmaceuticals

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

September 05, 2023
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Is Sanofi's (EPA:SAN) Recent Performance Tethered To Its Attractive Financial Prospects?

September 04, 2023
Sanofi's (EPA:SAN) stock is up by 5.0% over the past month. Given that the market rewards strong financials in the...
ENXTPA:EAPI
ENXTPA:EAPIPharmaceuticals

Euroapi S.A.'s (EPA:EAPI) market cap surged €56m last week, public companies who have a lot riding on the company were rewarded

August 31, 2023
Key Insights Significant control over Euroapi by public companies implies that the general public has more power to...
ENXTPA:BOI
ENXTPA:BOIPharmaceuticals

Boiron SA (EPA:BOI) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

August 25, 2023
Boiron's (EPA:BOI) stock is up by a considerable 38% over the past three months. However, we decided to pay attention...
ENXTPA:IPN
ENXTPA:IPNPharmaceuticals

Ipsen S.A. (EPA:IPN) most popular amongst private companies who own 31%, insiders hold 27%

August 17, 2023
Key Insights The considerable ownership by private companies in Ipsen indicates that they collectively have a greater...
ENXTPA:VIRP
ENXTPA:VIRPPharmaceuticals

Investing in Virbac (EPA:VIRP) five years ago would have delivered you a 119% gain

August 15, 2023
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Is There An Opportunity With Sanofi's (EPA:SAN) 47% Undervaluation?

August 08, 2023
Key Insights Using the 2 Stage Free Cash Flow to Equity, Sanofi fair value estimate is €177 Current share price of...
ENXTPA:MEDCL
ENXTPA:MEDCLPharmaceuticals

Individual investors who hold 53% of MedinCell S.A. (EPA:MEDCL) gained 13%, institutions profited as well

August 05, 2023
Key Insights MedinCell's significant individual investors ownership suggests that the key decisions are influenced by...
ENXTPA:EAPI
ENXTPA:EAPIPharmaceuticals

Analysts Are Updating Their Euroapi S.A. (EPA:EAPI) Estimates After Its Half-Yearly Results

August 04, 2023
It's been a good week for Euroapi S.A. ( EPA:EAPI ) shareholders, because the company has just released its latest...
ENXTPA:EAPI
ENXTPA:EAPIPharmaceuticals

Is Euroapi S.A. (EPA:EAPI) Trading At A 49% Discount?

August 02, 2023
Key Insights Using the 2 Stage Free Cash Flow to Equity, Euroapi fair value estimate is €24.50 Euroapi is estimated to...
ENXTPA:IPN
ENXTPA:IPNPharmaceuticals

Is Ipsen S.A.'s (EPA:IPN) Stock's Recent Performance A Reflection Of Its Financial Health?

July 30, 2023
Most readers would already know that Ipsen's (EPA:IPN) stock increased by 4.6% over the past three months. Since the...
ENXTPA:VETO
ENXTPA:VETOPharmaceuticals

Vetoquinol's (EPA:VETO) 12% CAGR outpaced the company's earnings growth over the same five-year period

July 30, 2023
When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying...
ENXTPA:VIRP
ENXTPA:VIRPPharmaceuticals

Insiders the biggest winners as Virbac SA's (EPA:VIRP) market cap rises to €2.4b

July 27, 2023
Key Insights Virbac's significant insider ownership suggests inherent interests in company's expansion A total of 2...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Sanofi (EPA:SAN) jumps 5.5% this week, though earnings growth is still tracking behind five-year shareholder returns

July 21, 2023
If you want to compound wealth in the stock market, you can do so by buying an index fund. But the truth is, you can...
ENXTPA:IPN
ENXTPA:IPNPharmaceuticals

Those who invested in Ipsen (EPA:IPN) three years ago are up 42%

July 12, 2023
Low-cost index funds make it easy to achieve average market returns. But if you invest in individual stocks, some are...
ENXTPA:VIRP
ENXTPA:VIRPPharmaceuticals

Is Weakness In Virbac SA (EPA:VIRP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

July 08, 2023
With its stock down 16% over the past month, it is easy to disregard Virbac (EPA:VIRP). However, a closer look at its...
ENXTPA:BOI
ENXTPA:BOIPharmaceuticals

Boiron's (EPA:BOI) earnings trajectory could turn positive as the stock soars 30% this past week

July 06, 2023
This month, we saw the Boiron SA ( EPA:BOI ) up an impressive 33%. But over the last half decade, the stock has not...
ENXTPA:VETO
ENXTPA:VETOPharmaceuticals

Is Vetoquinol SA's (EPA:VETO) Latest Stock Performance Being Led By Its Strong Fundamentals?

July 03, 2023
Vetoquinol's (EPA:VETO) stock up by 7.3% over the past three months. Given that the market rewards strong financials in...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

With 57% ownership of the shares, Sanofi (EPA:SAN) is heavily dominated by institutional owners

June 30, 2023
Key Insights Given the large stake in the stock by institutions, Sanofi's stock price might be vulnerable to their...
  • 1
  • 2
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.